Ex vivo drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with PICALM::MLLT10
Ex vivo drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with PICALM::MLLT10

Ex vivo drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with PICALM::MLLT10

Haematologica. 2025 Feb 27. doi: 10.3324/haematol.2024.286815. Online ahead of print.

ABSTRACT

Not available.

PMID:40013393 | DOI:10.3324/haematol.2024.286815